CA2007353A1 - Systeme therapeutique superficiel comprenant une substance antineoplastique active, particulierement du 5-fluorouracil - Google Patents

Systeme therapeutique superficiel comprenant une substance antineoplastique active, particulierement du 5-fluorouracil

Info

Publication number
CA2007353A1
CA2007353A1 CA2007353A CA2007353A CA2007353A1 CA 2007353 A1 CA2007353 A1 CA 2007353A1 CA 2007353 A CA2007353 A CA 2007353A CA 2007353 A CA2007353 A CA 2007353A CA 2007353 A1 CA2007353 A1 CA 2007353A1
Authority
CA
Canada
Prior art keywords
active substance
therapeutic system
fluorouracil
antineoplastic active
superficial therapeutic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2007353A
Other languages
English (en)
Other versions
CA2007353C (fr
Inventor
Walter Muller
Heinrich Kindel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LTS Lohmann Therapie Systeme AG
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2007353A1 publication Critical patent/CA2007353A1/fr
Application granted granted Critical
Publication of CA2007353C publication Critical patent/CA2007353C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
CA002007353A 1989-01-20 1990-01-09 Systeme therapeutique superficiel comprenant une substance antineoplastique active, particulierement du 5-fluorouracil Expired - Fee Related CA2007353C (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3901551A DE3901551A1 (de) 1989-01-20 1989-01-20 Superfizielles therapeutisches system mit einem gehalt an einem antineoplastischen wirkstoff, insbesondere 5-fluoruracil
DEP3901551.3 1989-01-20

Publications (2)

Publication Number Publication Date
CA2007353A1 true CA2007353A1 (fr) 1990-07-20
CA2007353C CA2007353C (fr) 1997-08-19

Family

ID=6372429

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002007353A Expired - Fee Related CA2007353C (fr) 1989-01-20 1990-01-09 Systeme therapeutique superficiel comprenant une substance antineoplastique active, particulierement du 5-fluorouracil

Country Status (22)

Country Link
US (1) US5077055A (fr)
EP (1) EP0379933B1 (fr)
JP (1) JPH0784378B2 (fr)
KR (1) KR960008226B1 (fr)
AT (1) ATE112174T1 (fr)
AU (1) AU631167B2 (fr)
CA (1) CA2007353C (fr)
CZ (1) CZ278718B6 (fr)
DD (1) DD291478A5 (fr)
DE (2) DE3901551A1 (fr)
DK (1) DK0379933T3 (fr)
ES (1) ES2063172T3 (fr)
FI (1) FI104150B1 (fr)
HU (1) HU205013B (fr)
IE (1) IE66737B1 (fr)
IL (1) IL92924A (fr)
NO (1) NO300617B1 (fr)
NZ (1) NZ232158A (fr)
PL (1) PL163294B1 (fr)
PT (1) PT92903B (fr)
SK (1) SK13290A3 (fr)
YU (1) YU47339B (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4020144A1 (de) * 1990-06-25 1992-01-09 Lohmann Therapie Syst Lts Pflaster mit hohem gehalt an weichmachenden inhaltsstoffen
TW283163B (fr) * 1993-08-19 1996-08-11 Nissan Chemical Ind Ltd
JPH07206710A (ja) * 1994-01-21 1995-08-08 Nitto Denko Corp 経皮投薬用テープ製剤
DE4416927C1 (de) * 1994-05-13 1995-08-31 Lohmann Therapie Syst Lts Vorrichtung zur Abgabe von Wirkstoffen aus Haftschmelzklebern, Verfahren zu ihrer Herstellung und ihre Verwendung
FR2738744B1 (fr) * 1995-09-20 1997-10-24 Oreal Patch cosmetique ou dermo-pharmaceutique contenant dans une matrice polymerique au moins un compose actif en particulier instable en milieu oxydant et au moins un agent hydro-absorbant
US6063398A (en) * 1995-09-20 2000-05-16 L'oreal Cosmetic or dermopharmaceutical patch containing, in an anhydrous polymeric matrix, at least one active compound which is, in particular, unstable in oxidizing mediums, and at least one water-absorbing agent
ES2196208T3 (es) * 1996-03-09 2003-12-16 Nitto Denko Corp Preparacion percutanea adhesiva.
FR2787459B1 (fr) * 1998-12-18 2001-02-16 Oreal Solution d'un polymere du type polyacrylique et/ou polyvinylique associe a une charge et a un agent keratolytique et dispositif cosmetique de nettoyage et de soin
DE19925519A1 (de) * 1999-06-04 2000-12-07 Lohmann Therapie Syst Lts Wundauflage zur gesteuerten Abgabe von Wirkstoff an Wunden und Verfahren zu ihrer Herstellung
DE10025328A1 (de) * 2000-05-23 2001-12-06 Lohmann Therapie Syst Lts Acetylsalicylsäure enthaltendes superfizielles therapeutisches System zur Behandlung von Hautschmerzen
FR2826261B1 (fr) * 2001-06-26 2005-03-25 Lmd Composition a usage topique comprenant un produit cytotoxique et son utilisation dans le traitement de l'alopeche
ITMI20041628A1 (it) * 2004-08-06 2004-11-06 Bouty S P A Sistema terapeutico a rilascio controllato per uso topico transdermico

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3734097A (en) * 1969-04-01 1973-05-22 Alza Corp Therapeutic adhesive tape
US3769071A (en) * 1971-06-04 1973-10-30 Minnesota Mining & Mfg Pressure sensitive adhesive tape comprising 5-fluorouracil
IN155486B (fr) * 1981-03-16 1985-02-09 Johnson & Johnson Prod Inc
JPS60123417A (ja) * 1983-12-07 1985-07-02 Nitto Electric Ind Co Ltd 薬物投与部材
US4697202A (en) * 1984-02-02 1987-09-29 Sri International Integrated circuit having dislocation free substrate
HU197847B (en) * 1984-03-01 1989-06-28 Sandoz Ag Process for producing therapeutical preparations suitable for transdermatic treating
DE3513938A1 (de) * 1985-04-18 1986-10-23 Merck Patent Gmbh, 6100 Darmstadt Cytostatikahaltiges pharmakadepot
AU561608B1 (en) * 1985-11-04 1987-05-14 Paco Research Corp. Transdermal vasoactive delivery
JPS63503540A (ja) * 1986-05-29 1988-12-22 フセソユーズヌイ、ナウチノ‐イスレドワーチェルスキー、イ、イスピタテルヌイ、インスチツート、メディツィンスコイ、チェフニキ 生物分解性ポリマー製の抗腫瘍性フィルム
DE3629304A1 (de) * 1986-08-28 1988-03-24 Lohmann Gmbh & Co Kg Transdermales therapeutisches system, seine verwendung und verfahren zu seiner herstellung
AU607172B2 (en) * 1986-12-22 1991-02-28 Cygnus, Inc. Diffusion matrix for transdermal drug administration
US4855142A (en) * 1987-02-27 1989-08-08 Ciba-Geigy Corporation Pharmaceutical plaster
DE3714140A1 (de) * 1987-04-28 1988-11-10 Lohmann Therapie Syst Lts Wirkstoffhaltiges pflaster zur kontrollierten verabreichung von wirkstoffen an die haut, seine verwendung sowie verfahren zur gesteuerten verabreichung von wirkstoffen an die haut
HU197519B (en) * 1987-06-22 1989-04-28 Biogal Gyogyszergyar Process for producing medicine form capable for penetrating through epidermis and suitable for intaking the agent through epidermis by kinetics of zero-grade
IE65163B1 (en) * 1987-06-29 1995-10-04 Squibb & Sons Inc Process for preparing a wound dressing comprising a hydrophilic acrylic adhesive layer

Also Published As

Publication number Publication date
NO900270D0 (no) 1990-01-19
IL92924A (en) 1994-01-25
DE59007292D1 (de) 1994-11-03
EP0379933A2 (fr) 1990-08-01
NO300617B1 (no) 1997-06-30
CZ13290A3 (en) 1993-10-13
DE3901551A1 (de) 1990-07-26
JPH02288826A (ja) 1990-11-28
FI104150B (fi) 1999-11-30
YU3390A (sh) 1992-07-20
DE3901551C2 (fr) 1992-01-02
IE900212L (en) 1990-07-20
AU631167B2 (en) 1992-11-19
ATE112174T1 (de) 1994-10-15
PT92903A (pt) 1990-07-31
JPH0784378B2 (ja) 1995-09-13
IE66737B1 (en) 1996-02-07
FI104150B1 (fi) 1999-11-30
KR960008226B1 (ko) 1996-06-21
AU4739089A (en) 1990-07-26
PL163294B1 (pl) 1994-03-31
HU900199D0 (en) 1990-03-28
US5077055A (en) 1991-12-31
SK277778B6 (en) 1994-12-07
NZ232158A (en) 1991-06-25
EP0379933A3 (fr) 1991-06-12
NO900270L (no) 1990-07-23
FI900315A0 (fi) 1990-01-19
DK0379933T3 (da) 1994-11-21
EP0379933B1 (fr) 1994-09-28
SK13290A3 (en) 1994-12-07
HUT55642A (en) 1991-06-28
CZ278718B6 (en) 1994-05-18
HU205013B (en) 1992-03-30
CA2007353C (fr) 1997-08-19
ES2063172T3 (es) 1995-01-01
DD291478A5 (de) 1991-07-04
PT92903B (pt) 1995-12-29
KR900011458A (ko) 1990-08-01
IL92924A0 (en) 1990-09-17
YU47339B (sh) 1995-01-31

Similar Documents

Publication Publication Date Title
HRP930871A2 (en) Therapeutic transdermal system containing turobuterol as the ve substance
CA2153572A1 (fr) Systeme therapeutique pour administration transdermique, avec la galanthamine comme principe actif
CA2030178A1 (fr) Dispositif therapeutique transdermique faisant appel a la buprenorphine comme composant actif
CA2007353A1 (fr) Systeme therapeutique superficiel comprenant une substance antineoplastique active, particulierement du 5-fluorouracil
MY111126A (en) Transdermal therapeutic system comprising the active substance acetylsalicylic acid.
WO1997004818A3 (fr) Systeme therapeutique transdermique pour administrer des constituants actifs au corps humain par voie cutanee
CA2146645A1 (fr) Emplatre pour l'administration transdermique d'ingredients alcalins volatils, possedant des proprietes pharmaceutiques; methode de preparation
CA2387143A1 (fr) Systeme therapeutique transdermique a base d'hydrochlorure de tulobuterol utilise pour administrer le bronchodilatateur tulobuterol par l'intermediaire de la peau
CA2278639A1 (fr) Systeme a emplatre transdermique ou topique avec matrice au polyacrylate a proprietes physiques ameliorees
MY111688A (en) Transdermal therapeutic system comprising the active substance 17-b-estradiol (anhydous)
NZ509215A (en) Transdermal plaster preparation containing at least one active ingredient which influences blood serum lipid levels
WO1999007349A3 (fr) Systeme therapeutique transdermique (tts) permettant d'introduire un principe actif dans un organisme par la peau et procede d'application sur la peau
CA2370023A1 (fr) Systeme therapeutique transdermique contenant un neuroleptique tres actif
CA2414753A1 (fr) Systeme therapeutique dermique contenant de l'acide 2-(3-benzophenyl)-propionique ou de l'acide [0-(2,6-dichloranilino)-phenyl]-acetique
CA2172401A1 (fr) Systeme therapeutique transdermique avec l'acide acetylsalicylique comme substance active
CA2198092A1 (fr) Systeme therapeutique transdermique avec protection contre l'hydrolyse

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed